Table 1 Comparison of blood parameters and neonatal parameters between the groups.

From: Maternal blood endometase level as a predictive biomarker for hypertensive disorders during pregnancy: a prospective cohort study

 

Preeclampsia (n = 30)

Gestational Hypertension (n = 30)

Control

(n = 30)

p value

Difference

Albumin**

32(22–45)

36(32–39)

36(30–41)

< 0.001

2–3 > 1

Protein/Creatinine Ratio in Spot Urine**

2086(231-11623)

142(86–299)

129(64–350)

< 0.001

1 > 2–3

Platelet*

237.77 ± 73.58

232.43 ± 67.27

235.53 ± 62

0.954

 

AST**

23.5(6-119)

16.5(9–41)

15(8–39)

< 0.001

1 > 2–3

ALT**

13.5(5-301)

11(6–53)

9.5(4–31)

0.065

 

LDH**

296(140–818)

232.5(134–372)

199.5(129–357)

< 0.001

1 > 2–3

Uric acid**

5.9(2.4–9.9)

4.2(1.9–7.7)

3.1(2-4.5)

< 0.001

1 > 2 > 3

Age*

31.13 ± 6.36

30.37 ± 6.52

27.87 ± 5.33

0.100

 

Birth Week**

31.5(24–37)

37(33–40)

38(25–40)

< 0.001

2–3 > 1

Newborn Weight*

1391.61 ± 568.26

2867.31 ± 605.72

2728.33 ± 704.05

< 0.001

2–3 > 1

1st Minute APGAR Score**

6(0–8)

7.5(3–9)

8(3–9)

< 0.001

2–3 > 1

5th Minute APGAR Score**

8(0–9)

8.5(7–10)

9(6–10)

< 0.001

3 > 1–2

  1. p < 0.05, *One-way analysis of variance (ANOVA), **Kruskal Wallis H Test.